VITAMIN D THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的目的是测试不同剂量的维生素D在系统性红斑狼疮（SLE）患者中的安全性和有效性。 长期目标是确定维生素D是否可用于治疗和/或预防SLE。 要求受试者参加本研究，因为他们年满18岁，患有SLE，参加过SLEIGH研究，并同意联系他们以获得参加未来研究的机会。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the safety and effectiveness of different doses of vitamin D in patients with Systemic Lupus Erythematosus (SLE). A long term goal is to determine if vitamin D could be used as a treatment and/or preventative of SLE. Subjects are being asked to participate in this study because they are 18 years of age or older, have SLE, have participated in the SLEIGH study, and have agreed to be contacted for the opportunity to participate in future studies.